Congressional briefing for Hill staff on the need for improved regulation of cannabidiol (CBD) products by the Food and Drug Administration (FDA).

On Dec. 5, the National Association of County Behavioral Health & Developmental Disability Directors (NACBHDD), together with the National Association for Rural Mental Health (NARMH) and the National Association of Social Workers (NASW), hosted a Congressional briefing for Hill staff on the need for improved regulation of cannabidiol (CBD) products by the Food and Drug Administration (FDA).

Read the "Behavioral Health Executive" article
by Ron Manderscheid, PhD, Executive Director, NACBHDD and NARMH.

Open the article

Why It's Critical that the FDA Act on CBD

Read the "Behavioral Health Executive" article
"Why It's Critical that the FDA Act on CBD"

Open the article